Repaglinide
CAS 135062-02-1 18 FDA-DMF suppliersSmall Molecule
Overview
Repaglinide is an oral medication used to manage Type 2 diabetes mellitus by stimulating the release of insulin from pancreatic beta cells. It is classified as a meglitinide and helps control blood sugar levels post-prandially.
API suppliers (28)
Suppliers of Repaglinide backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- Sun Pharmaceutical Industries LimitedIndia1 active DMF
- Dr. Reddy's Laboratories Ltd.India1 active DMF
- USV PRIVATE LTD1 active DMF
- JUBILANT BIOSYS LTD1 active DMF
- Torrent PharmaceuticalsIndia1 active DMF
- BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG1 active DMF
- USV PRIVATE LTD1 active DMF
- Biocon LimitedIndia1 active DMF
- Dr. Reddy's Laboratories Ltd.India1 active DMF
- Sun Pharmaceutical Industries LimitedIndia1 active DMF
- USV PRIVATE LTD1 active DMF
- Biocon LimitedIndia1 active DMF
- BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG1 active DMF
- Macleods Pharmaceuticals Ltd.India1 active DMF
- Dr. Reddy's Laboratories Ltd.India1 active DMF
- Sun Pharmaceutical Industries LimitedIndia1 active DMF
- USV PRIVATE LTD1 active DMF
- Biocon LimitedIndia1 active DMF
- BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG1 active DMF
- Macleods Pharmaceuticals Ltd.India1 active DMF
- APITORIA PHARMA PRIVATE LTDIndia1 active DMF
- JUBILANT BIOSYS LTD1 active DMF
- Torrent PharmaceuticalsIndia1 active DMF
- Zhejiang Hisun Pharmaceutical Co., Ltd.China
- Zakłady Farmaceutyczne Polpharma S.A.Poland
Showing 25 of 28 suppliers — see the full list in the app.
Therapeutic areas
DiabetesEndocrinology
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.